A 52-year-old female presents to the clinic with complaints…

A 52-year-old female presents to the clinic with complaints of amenorrhea for 6 months. She denies pain with urination or with sexual intercourse. She denies using any birth control. She reports some concerns of flushing and increase sweating. Which of the following is the most accurate interpretation of these findings?  

A company conducts a bioequivalence study. The test product…

A company conducts a bioequivalence study. The test product has an AUC ratio of 1,02 and a Cmax ratio of 1,00 compared with the reference product. However, the lower limit of the 90 % confidence interval for AUC is 0,78. What is the most appropriate regulatory conclusion?

An active substance manufacturer prepares an Active Substanc…

An active substance manufacturer prepares an Active Substance Master File (ASMF). The detailed crystallisation process and purification steps are included in the Restricted (Closed) Part because they constitute confidential manufacturing know-how. However, the crystallisation process determines the polymorphic form and particle size distribution of the active substance, both of which may influence dissolution of the finished product. Which approach is most appropriate?

An API manufacturer produces an active substance through a m…

An API manufacturer produces an active substance through a multi-step synthesis. During regulatory review, the assessor asks the manufacturer to identify the final intermediate immediately preceding formation of the active substance and to explain its significance in the manufacturing process. Which statement is most appropriate?